Basic Study
Copyright ©The Author(s) 2022.
World J Hepatol. Dec 27, 2022; 14(12): 1997-2011
Published online Dec 27, 2022. doi: 10.4254/wjh.v14.i12.1997
Figure 3
Figure 3 Comparisons of clinical and phenotypic features between the immune-specific subtypes of hepatitis B virus + hepatocellular carcinoma. A: K–M curves showing that Imm-H has significantly higher 5-year overall survival and disease-free survival rates than Imm-L. The log-rank test P values are shown; B: Imm-H has significantly lower stemness and intratumor heterogeneity than Imm-L; C: Imm-H has significantly lower tumor purity than Imm-L. The one-tailed Mann–Whitney U test P values are shown in (B, C).